buy

Acadia Pharmaceuticals buy JPMorgan Chase & Co.

Acadia Pharmaceuticals

Start price

€19.87

/ 50%

Target price

04.03.27

Performance (%)

Price

Summary

This prediction is currently active. With a performance of , the BUY prediction for Acadia Pharmaceuticals by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 04.03.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Acadia Pharmaceuticals
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Acadia Pharmaceuticals diskutieren

Prediction Buy

Perf. (%)

Target price 29.315

Change

Ends at

ACADIA Pharmaceuticals (ACAD) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.

Ratings data for ACAD provided by MarketBeat

JPMorgan Chase & Co.